Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.

Vaccines (Basel) · 2022 · PMC9413082 · PMID 36016218

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In our previous report, a single dose of ChAdOx1 MERS vaccine showed partial but highly significant protection in seropositive camels over 3 weeks follow-up period.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.